| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |